normal human cervical epithelial cells hucec (ATCC)
Structured Review

Normal Human Cervical Epithelial Cells Hucec, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 595 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normal human cervical epithelial cells hucec/product/ATCC
Average 97 stars, based on 595 article reviews
Images
1) Product Images from "Circular RNA circLMO1 Suppresses Cervical Cancer Growth and Metastasis by Triggering miR-4291/ ACSL4 -Mediated Ferroptosis"
Article Title: Circular RNA circLMO1 Suppresses Cervical Cancer Growth and Metastasis by Triggering miR-4291/ ACSL4 -Mediated Ferroptosis
Journal: Frontiers in Oncology
doi: 10.3389/fonc.2022.858598
Figure Legend Snippet: Features of circLMO1. (A) Schematic diagram of the formation of circLMO1. The qPCR primers used to evaluate the linear sequence of circLMO1, the convergent primers, are represented by red triangles. The qPCR primers used to evaluate the reverse splice site of circLMO1, the divergent primers, are represented by purple triangles. (B) Sanger sequencing of the reverse splice site of circLMO1. (C) qPCR analysis of circLMO1 level in DNA and cDNA derived from C33A cells using convergent primers and divergent primers. (D) Oligo (dT)18 primers or random primers was used to synthesize first-strand cDNA, and then qPCR analysis was performed to evaluate the level of circLMO1 and mLMO1 in these cDNAs. The value of the random primer is used as a reference. (E) Total RNA was treated with RNase R, and then qPCR analysis were performed to evaluate circLMO1 and mLMO1 level. (F) qPCR analysis was performed to assess circLMO1 expression in various cervical cancer cell lines (SiHa, CaSki, C33A, and HeLa) and normal cervical epithelial cell lines (HUCEC). (G) qPCR analysis was performed to assess circLMO1 level in cervical cancer tissues (n = 31) and matched normal tissues. (H) qPCR analysis was performed to assess circLMO1 level in different FIGO stages of cervical cancer. *p < 0.05, **p < 0.01, ***p < 0.001.
Techniques Used: Sequencing, Derivative Assay, Expressing
Figure Legend Snippet: CircLMO1 acts as a sponge for miR-4291 in cervical cancer cells. (A) FISH assay were carried out to assess circLMO1 cell localization in C33A and CaSki cells. The RNA probe targeting circLMO1 was stained green and the nucleus was stained blue. (B) qPCR analysis of circLMO1 levels in the cytoplasm and nucleus of C33A cells. U6 was used as a positive control in the nucleus, and β-actin was used as a positive control in the cytoplasm. (C) AGO2 antibody was used to perform RIP assay to determine the combination of circLMO1 and AGO2 in CaSki cells. (D) qPCR analysis was performed to assess miRNAs expression in CaSki and HUCEC cells. (E) Schematic diagram of the predicted miR-4291-circLMO1 interaction. (F–H) After co-transfection with miR-4291 (or its mutant) and circLMO1-wt luciferase reporter gene (or its mutant), luciferase activity was assessed in CaSki and C33A cells. After transfection with biotin-labelled miR-4291, qPCR analysis was performed to assess circLMO1 level in the streptavidin precipitation complex from CaSki cells (I) or C33A cells (J) . (K) The co-localization of circLMO1 and miR-4291 analysed through double FISH assay in C33A cells. *p < 0.05, **p < 0.01.
Techniques Used: Staining, Positive Control, Expressing, Cotransfection, Mutagenesis, Luciferase, Activity Assay, Transfection

